News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
126 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17567)
Month
January (2478)
February (2705)
March (2920)
April (2815)
May (3257)
June (3002)
July (2537)
August (2870)
September (2818)
October (3675)
November (3195)
December (2498)
Day
1 (123)
2 (160)
3 (107)
6 (130)
7 (165)
8 (148)
9 (194)
10 (124)
11 (1)
13 (157)
14 (153)
15 (143)
16 (138)
17 (95)
20 (54)
21 (128)
22 (143)
23 (152)
24 (108)
27 (126)
28 (156)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
6
7
8
9
10
11
13
14
15
16
17
20
21
22
23
24
27
28
Drug Development
Clinical Trial Results Show That Peregrine Pharmaceuticals, Inc.'s First-In-Class Anti-Viral Agent Tarvacin(TM) Is Safe And Well-Tolerated In HCV Patients
February 27, 2006
·
6 min read
Deals
Chiron Corporation Confirms Proposed Purchase Of BETASERON Assets By Schering AG Under Change-In-Control Option
February 27, 2006
·
1 min read
Drug Development
Cell Genesys, Inc. Reports Encouraging Follow-Up Survival Data From Second Phase 2 Trial Of GVAX(R) Immunotherapy For Prostate Cancer
February 27, 2006
·
7 min read
Pharm Country
Lifetime Health Medical Group Of Western New York To Provide Electronic Prescribing To 30,000 Additional Patients
February 27, 2006
·
3 min read
Business
BioScrip CEO Henry F. Blissenbach To Retire
February 27, 2006
·
1 min read
Pharm Country
Medco Health Solutions, Inc. Executives To Present At Investor Conferences
February 27, 2006
·
2 min read
Pharm Country
American Academy of Allergy, Asthma and Immunology (AAAAI) Release: Preliminary Data From Landmark Survey Uncovers Trends In Quality Of Life And Occupational Consequences Of Allergy Symptoms
February 27, 2006
·
4 min read
Business
BioSante Pharmaceuticals, Inc. Signs Option And License For Its CaP Technology For Use In Aesthetic Medicine
February 27, 2006
·
1 min read
Genetown
Ariad Pharmaceuticals, Inc. To Webcast Presentation At The SG Cowen & Co., LLC 26th Annual Healthcare Conference
February 27, 2006
·
1 min read
Teva Pharmaceutical Industries Limited Announces Exercise Of Over-Allotment Option For Convertible Debentures
February 27, 2006
·
1 min read
Previous
8 of 13
Next
